Up-regulated miR-155-5p promotes cell proliferation, invasion and metastasis in colorectal carcinoma

International Journal of Clinical and Experimental Pathology

Volumn 8, Issue 6, 2015, Pages 6988-6994

  Qu, Yan Li ^a   Wang, Hai Feng ^a   Sun, Zhen Qiang ^a   Tang, Yong ^a   Han, Xiao Na ^a   Yu, Xian Bo ^b   Liu, Kun ^a  

^a XINJIANG MEDICAL UNIVERSITY   (China)

^b Cangzhou People's Hospital   (China)

Author keywords

Colorectal carcinoma; HT 29 cell; Invasion; miR 155 5p; Proliferation; Tumorigenesis

Indexed keywords

MICRORNA; MIRN155 MICRORNA, HUMAN;

AGED; CANCER GRADING; CANCER STAGING; CARCINOMA; CELL MOTION; CELL PROLIFERATION; COLORECTAL NEOPLASMS; FEMALE; GENE EXPRESSION REGULATION; GENETIC TRANSFECTION; GENETICS; HT-29 CELL LINE; HUMAN; MALE; METABOLISM; MIDDLE AGED; PATHOLOGY; REAL TIME POLYMERASE CHAIN REACTION; RETROSPECTIVE STUDY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SECONDARY; TUMOR INVASION; UPREGULATION;

AGED; CARCINOMA; CELL MOVEMENT; CELL PROLIFERATION; COLORECTAL NEOPLASMS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HT29 CELLS; HUMANS; MALE; MICRORNAS; MIDDLE AGED; NEOPLASM GRADING; NEOPLASM INVASIVENESS; NEOPLASM STAGING; REAL-TIME POLYMERASE CHAIN REACTION; RETROSPECTIVE STUDIES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRANSFECTION; UP-REGULATION;

EID: 84938633227     PISSN: None     EISSN: 19362625     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Fan NJ, Kang R, Ge XY, Li M, Liu Y, Chen HM and Gao CF. Identification alpha-2-HS-glycoprotein precursor and tubulin beta chain as serology diagnosis biomarker of colorectal cancer. Diagn Pathol 2014; 9: 53.
2. Chen C, Wang L, Liao Q, Huang Y, Ye H, Chen F, Xu L, Ye M and Duan S. Hypermethylation of EDNRB promoter contributes to the risk of colorectal cancer. Diagn Pathol 2013; 8: 199.
3. Liu F, Xiong Y, Zhao Y, Tao L, Zhang Z, Zhang H, Liu Y, Feng G, Li B, He L, Ma J, Qin S and Yang Y. Identification of aberrant microRNA expression pattern in pediatric gliomas by microarray. Diagn Pathol 2013; 8: 158.
4. Lai EC. Micro RNAs are complementary to 39UTR sequence motifs that mediate negative post-transcriptional regulation. Nat Genet 2002; 30: 363-364.
5. Berezikov E, Guryev V, van de Belt J, Wienholds E, Plasterk RH and Cuppen E. Phylogenetic shadowing and computational identification of human microRNA genes. Cell 2005; 120: 21-24.
6. Xie X, Lu J, Kulbokas EJ, Golub TR, Mootha V, Lindblad-Toh K, Lander ES and Kellis M. Systematic discovery of regulatory motifs in human promoters and 39UTRs by comparison of several mammals. Nature 2005; 434: 338-345.
7. Mezzanzanica D, Bagnoli M, De Cecco L, Valeri B and Canevari S. Role of microRNAs in ovarian cancer pathogenesis and potential clinical implications. Int J Biochem Cell Biol 2010; 42: 1262-1272.
8. Chen X, Gong J, Zeng H, Chen N, Huang R, Huang Y, Nie L, Xu M, Xia J, Zhao F, Meng W and Zhou Q. MicroRNA145 targets BNIP3 and suppresses prostate cancer progression. Cancer Res 2010; 70: 2728-2738.
9. Svrcek M, El-Murr N, Wanherdrick K, Dumont S, Beaugerie L, Cosnes J, Colombel JF, Tiret E, Fléjou JF, Lesuffleur T and Duval A. Overexpression of microRNAs-155 and 21 targeting mismatch repair proteins in inflammatory bowel diseases. Carcinogenesis 2013; 34: 828-834.
10. Valeri N, Gasparini P, Fabbri M, Braconi C, Veronese A, Lovat F, Adair B, Vannini I, Fanini F, Bottoni A, Costinean S, Sandhu SK, Nuovo GJ, Alder H, Gafa R, Calore F, Ferracin M, Lanza G, Volinia S, Negrini M, McIlhatton MA, Amadori D, Fishel R and Croce CM. Modulation of mismatch repair and genomic stability by miR-155. PNAS 2010; 107: 6982-6987.
11. Yamamoto H, Adachi Y, Taniguchi H, Kunimoto H, Nosho K, Suzuki H and Shinomura Y. Interrelationship between microsatellite instability and microRNA in gastrointestinal cancer. World J Gastroenterol 2012; 18: 2745-2755.
12. Liu X, Zhang Z, Sun L, Chai N, Tang S, Jin J, Hu H, Nie Y, Wang X, Wu K, Jin H and Fan D. MicroRNA-499-5p promotes cellular invasion and tumor metastasis in colorectal cancer by targeting FOXO4 and PDCD4. Carcinogenesis 2011; 32: 1798-1805.
13. Liu WJ, Zhao YP, Zhang TP, Zhou L, Cui QC, Zhou WX, You L, Chen G and Shu H. MLH1 as a direct target of MiR-155 and a potential predictor of favorable prognosis in pancreaticcancer. J Gastrointest Surg 2013; 17: 1399-1405.
14. Wang Y, Li J, Tong L, Zhang J, Zhai A, Xu K, Wei L and Chu M. The prognostic value of miR-21 and miR-155 in non-small-cell lung cancer: a meta-analysis. Jpn J Clin Oncol 2013; 43: 813-820.
15. Xu TP, Zhu CH, Zhang J, Xia R, Wu FL, Han L, Shen H, Liu LX and Shu YQ. MicroRNA-155 expression has prognostic value in patients with non-small cell lung cancer and digestive system carcinomas. Asian Pac J Cancer Prev 2013; 14: 7085-7090.
16. Tsang WP and Kwok TT. The miR-18a microRNA functions as a potential tumor suppressor by targeting on K-Ras. Carcinogenesis 2009; 30: 953-959.
17. Liu L, Chen L, Xu Y, Li R and Du X. microRNA-195 promotes apoptosis and suppresses tumorigenicity of human colorectal cancer cells. Biochem Biophys Res Commun 2010; 400: 236-240.
18. Yamakuchi M, Ferlito M and Lowenstein CJ. miR-34a repression of SIRT1 regulates apoptosis. Proc Natl Acad Sci U S A 2008; 105: 13421-13426.
19. Hu M, Xia M, Chen X, Lin Z, Xu Y, Ma Y and Su L. MicroRNA-141 regulates Smad-interacting protein 1 (SIP1) and inhibits migration and invasion of colorectal cancer cells. Dig Dis Sci 2010; 55: 2365-2372.
20. Li W, Han W, Zhao X and Wang H. Changes of expression of miR-155 in colitis-associated colonic carcinogenesis. Zhonghua Zhong Liu Za Zhi 2014; 36: 257-262.
21. Pan W, Tang W, Yuan W, Yu Q, Zuo W, Xu C and Ma J. Expression and clinical significance of plasma small RNA in patients with pancreatic cancer. Zhonghua Zhong Liu Za Zhi 2014; 36: 351-354.
22. Jurkovicova D, Magyerkova M, Kulcsar L, Krivjanska M, Krivjansky V, Gibadulinova A, Oveckova I and Chovanec M. miR-155 as a diagnostic and prognostic marker in hematological and solid malignancies. Neoplasma 2014; 61: 241-251.
23. Sochor M, Basova P, Pesta M, Dusilkova N, Bartos J, Burda P, Pospisil V and Stopka T. Oncogenic microRNAs: miR-155, miR-19a, miR-181b, and miR-24 enable monitoring of early breast cancer in serum. BMC Cancer 2014; 14: 448.
24. Cui B, Chen L, Zhang S, Mraz M, Fecteau JF, Yu J, Ghia EM, Zhang L, Bao L, Rassenti LZ, Messer K, Calin GA, Croce CM and Kipps TJ. MicroRNA-155 influences B-cell receptor signaling and associates with aggressive disease in chronic lymphocytic leukemia. Blood 2014; 124: 546-554.
25. Hongliang C, Shaojun H, Aihua L and Hua J. Correlation between expression of miR-155 in colon cancer and serum carcinoembryonic antigen level and its contribution to recurrence and metastasis forecast. Saudi Med J 2014; 35: 547-553.
26. Dinami R, Ercolani C, Petti E, Piazza S, Ciani Y, Sestito R, Sacconi A, Biagioni F, le Sage C, Agami R, Benetti R, Mottolese M, Schneider C, Blandino G and Schoeftner S. miR-155 Drives Telomere Fragility in Human Breast Cancer by Targeting TRF1. Cancer Res 2014; 74: 4145-4156.
27. Farooqi AA, Qureshi MZ, Coskunpinar E, Naqvi SK, Yaylim I and Ismail M. MiR-421, miR-155 and miR-650: emerging trends of regulation of cancer and apoptosis. Asian Pac J Cancer Prev 2014; 15: 1909-1912.
28. Huang C, Li H, Wu W, Jiang T and Qiu Z. Regulation of miR-155 affects pancreatic cancer cell invasiveness and migration by modulating the STAT3 signaling pathway through SOCS1. Oncol Rep 2013; 30: 1223-1230.
29. Palma CA, Al Sheikha D, Lim TK, Bryant A, Vu TT, Jayaswal V and Ma DD. MicroRNA-155 as an inducer of apoptosis and cell differentiation in Acute Myeloid Leukaemia. Mol Cancer 2014; 13: 79.
30. Yuhas Y, Berent E and Ashkenazi S. Effect of nitric oxide on microRNA-155 expression in human hepatic epithelial cells. Inflamm Res 2014; 63: 591-596.
31. Zhang CM, Zhao J and Deng HY. MiR-155 promotes proliferation of human breast cancer MCF-7 cells through targeting tumor protein 53-induced nuclear protein 1. J Biomed Sci 2013; 20: 79.
32. Yu F, Jia X, Du F, Wang J, Wang Y, Ai W and Fan D. miR-155-deficient bone marrow promotes tumor metastasis. Mol Cancer Res 2013; 11: 923-936.
33. Gasparini P, Lovat F, Fassan M, Casadei L, Cascione L, Jacob NK, Carasi S, Palmieri D, Costinean S, Shapiro CL, Huebner K and Croce CM. Protective role of miR-155 in breast cancer through RAD51 targeting impairs homologous recombination after irradiation. Proc Natl Acad Sci U S A 2014; 111: 4536-4541.
34. Li H, Xie S, Liu M, Chen Z, Liu X, Wang L, Li D and Zhou Y. The clinical significance of downregulation of mir-124-3p, mir-146a-5p, mir-155-5p and mir-335-5p in gastric cancer tumorigenesis. Int J Oncol 2014; 45: 197-208.